Experienced in Thyroid Dysgenesis

Yen-chuan C. Ou

81 Lingnan North Road, 
Foshan, CN 
Experienced in Thyroid Dysgenesis
81 Lingnan North Road, 
Foshan, CN 
OverviewLocationsClinical Research

Overview

Yen-chuan Ou practices in Foshan, China. Ou is rated as an Experienced expert by MediFind in the treatment of Thyroid Dysgenesis. Their top areas of expertise are Urothelial Cancer, Prostate Cancer, Japanese Encephalitis, Prostatectomy, and Nephrectomy.

Their clinical research consists of co-authoring 149 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Thyroid Dysgenesis.

Locations

81 Lingnan North Road, Foshan, 528000, China
Other Locations
139 Renmin Road, Changsha, 410011, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drug: Fuzuloparib+Abiraterone Acetate+Prednisone
Study Phase: Phase 3
An Open-Label, Single-Arm, Multi-center Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Patients With Advanced/Metastatic Renal Cell Carcinoma
An Open-Label, Single-Arm, Multi-center Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Patients With Advanced/Metastatic Renal Cell Carcinoma
Enrollment Status: Completed
Publish Date: June 26, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

149 Total Publications

Laparoscopic versus robotic total extraperitoneal (TEP) inguinal hernia repair: a multicenter, propensity score weighted study.
Laparoscopic versus robotic total extraperitoneal (TEP) inguinal hernia repair: a multicenter, propensity score weighted study.
Journal: Hernia : the journal of hernias and abdominal wall surgery
Published: June 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ou's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile